KJHP
NDRA icon

K.J. Harrison & Partners’s ENDRA Life Sciences NDRA Stock Holding History

K.J. Harrison & Partners’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$169K – 375
2021
Q1 		$169K Sell
2
-6
-75% -$449K 0.03% 256
2020
Q4 		$208K Buy
8
+3
+60% +$80.1K 0.03% 241
2020
Q3 		$126K Buy
+5
New +$154K 0.03% 214

Other funds holding NDRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
5L
55I LLC Boston, Massachusetts $3.58B AUM 17.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

K.J. Harrison & Partners's NDRA Position: Q2 2021 in Review

K.J. Harrison & Partners sold out of ENDRA Life Sciences (NDRA) in Q2 2021, closing a stake of 2 shares — an estimated $169K sold.

K.J. Harrison & Partners first reported a position in NDRA in Q3 2020 and held it in 3 quarters. The position peaked at $208K in Q4 2020. 14 funds tracked by Wall St. Rank hold NDRA as of Q2 2021.

  • K.J. Harrison & Partners reported no remaining ENDRA Life Sciences position as of Q2 2021 after selling out during the quarter.
  • K.J. Harrison & Partners sold 2 ENDRA Life Sciences shares in Q2 2021, an estimated $169K.
  • K.J. Harrison & Partners first reported a position in ENDRA Life Sciences in Q3 2020 and held it in 3 quarters.
  • K.J. Harrison & Partners's ENDRA Life Sciences position peaked at $208K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2021.

Based on K.J. Harrison & Partners's 13F filing for Q2 2021, filed 4 Aug 2021.